Ticker > Company >

Shree Ganesh Remed. share price

Shree Ganesh Remedies Ltd.

  52.61 K   170   9 NSE: SGRL BSE: 540737 SECTOR: Pharmaceuticals & Drugs

665.90
-30.10 (-4.32%)
NSE: 09 Sep 4:00 PM

Price Summary

Today's High

₹ 708

Today's Low

₹ 653.5

52 Week High

₹ 722

52 Week Low

₹ 477.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

854.86 Cr.

Enterprise Value

872.08 Cr.

No. of Shares

1.28 Cr.

P/E

55.34

P/B

5.21

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  127.86

CASH

13.45 Cr.

DEBT

30.67 Cr.

Promoter Holding

72.84 %

EPS (TTM)

₹  12.03

Sales Growth

0.63%

ROE

11.53 %

ROCE

14.62%

Profit Growth

-23.05 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year0.63%
3 Year6.15%
5 Year17.37%

Profit Growth

1 Year-23.05%
3 Year5.39%
5 Year12.75%

ROE%

1 Year11.53%
3 Year18.56%
5 Year20.02%

ROCE %

1 Year14.62%
3 Year20.66%
5 Year23.38%

Debt/Equity

0.1882

Price to Cash Flow

35.99

Interest Cover Ratio

7.7422

CFO/PAT (5 Yr. Avg.)

1.18246488241528

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 72.84 0.00
Mar 2026 72.84 0.00
Dec 2025 72.80 0.00
Sep 2025 72.80 0.00
Jun 2025 72.80 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 20.6591666666667% over the past 3 years.
  • The Company has been maintaining an effective average operating margins of 29.94318% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 3.3945.
  • The company has a good cash flow management; CFO/PAT stands at 1.18246488241528.
  • The company has a high promoter holding of 72.84%.

 Limitations

  • The company has shown a poor profit growth of 5.38752173318411% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.1547483687538% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 24.67 30.32 21.11 33.2 14.36
Total Expenditure 17.37 20.7 14.38 21.82 11.01
Operating Profit 7.3 9.62 6.73 11.38 3.35
Other Income 0.66 0.69 0.66 1.02 0.94
Interest 0.94 1.01 0.74 0.88 0.32
Depreciation 2.42 2.59 2.67 2.8 2.44
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.6 6.71 3.98 8.72 1.53
Tax 1.15 1.76 0.89 2.45 0.41
Profit After Tax 3.45 4.96 3.1 6.27 1.12
Adjusted EPS (Rs) 2.69 3.86 2.41 4.89 0.87

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 71.29 91.36 125.9 108.6 109.29
Total Expenditure 53.37 67.92 84.09 69.38 74.27
Operating Profit 17.92 23.44 41.81 39.21 35.02
Other Income 3.57 0.72 3.07 3.73 3.03
Interest 0.15 0.18 0.6 2.08 3.56
Depreciation 3.34 3.74 6.11 9.57 10.47
Exceptional Items 0 0 0 0 0
Profit Before Tax 18.01 20.24 38.17 31.3 24.01
Tax 4.61 5.05 10.05 8.2 6.24
Net Profit 13.4 15.18 28.12 23.1 17.77
Adjusted EPS (Rs.) 11.08 12.14 21.89 17.99 13.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 12.01 12.51 12.84 12.84 12.84
Total Reserves 49.57 74.69 109.26 132.36 150.18
Borrowings 0 30.44 29.12 29.48 21.25
Other N/C liabilities 0.4 0.14 1.04 1.12 1.78
Current liabilities 15.04 25.15 25.96 24.23 26.78
Total Liabilities 77.02 142.92 178.22 200.02 212.83
Assets
Net Block 27.19 58.03 80.55 95 104.66
Capital WIP 3.09 15.16 16.63 8.34 12.38
Intangible WIP 0 0.24 0.29 0.43 0.49
Investments 0.08 0.08 0.16 0.16 0.16
Loans & Advances 0.61 2.15 3.18 10.5 4.19
Other N/C Assets 1.13 1.03 0.01 0 0.04
Current Assets 44.91 66.23 77.4 85.58 90.92
Total Assets 77.02 142.92 178.22 200.02 212.83
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 18.01 20.24 38.17 31.3 24.01
Adjustment -2.49 6.48 5.88 11.15 11.62
Changes in Assets & Liabilities 1.91 -3.72 -5.47 -1.73 -7.07
Tax Paid -4.01 -5.9 -8.14 -10.05 -4.81
Operating Cash Flow 13.42 17.1 30.45 30.66 23.75
Investing Cash Flow -11.91 -50.98 -33.18 -35.48 -8.6
Financing Cash Flow -1.09 38.66 9.85 -1.06 -11.7
Net Cash Flow 0.42 4.77 7.12 -5.88 3.46

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 72.80 72.80 72.80 72.84 72.84
chandulal manubhai kothia... 48.76 48.76 48.76 48.76 48.76
gunjan chandulal kothia 3.21 3.21 3.21 3.21 3.21
hanshaben chandubhai koth... 11.43 11.43 11.43 11.43 11.43
hetvi ketankumar patel 1.66 1.66 1.66 1.66 1.66
kothia ashokkumar manubha... 0.08 0.08 0.08 0.08 0.08
manubhai jivabhai kothiya... 1.84 1.84 1.84 1.84 1.84
parth chandulal kothia 1.03 1.03 1.03 1.06 1.06
pooja gunjan kothia 4.79 4.79 4.79 4.79 4.79
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 27.20 27.20 27.20 27.16 27.16
gunjan jayantibhai dhoraj... 1.70 1.70 1.70 1.70 1.70
v naga raja naidu 1.26 1.27 1.27 1.27 1.27

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY26
Presentation Q1FY27

Company News

Shree Ganesh Remed. - Quaterly Results 15 May, 12:00 AM Shree Ganesh Remedies informs about outcome of board meeting 14 May, 5:19 PM Shree Ganesh Remed. - Quaterly Results 24 Jan, 12:00 AM Shree Ganesh Remedies informs about outcome of board meeting 23 Jan, 5:14 PM Shree Ganesh Remed. - Quaterly Results 8 Nov, 12:00 AM Shree Ganesh Remedies informs about outcome of board meeting 1 Aug, 5:30 PM Shree Ganesh Remed. - Quaterly Results 1 Aug, 4:56 PM Shree Ganesh Remed. - Quaterly Results 1 Aug, 4:56 PM Shree Ganesh Remed. - Quaterly Results 1 Aug, 4:56 PM Shree Ganesh Remed. - Quaterly Results 19 May, 6:03 PM Shree Ganesh Remed. - Quaterly Results 19 May, 6:03 PM Shree Ganesh Remed. - Quaterly Results 19 May, 6:03 PM Shree Ganesh Remedies informs about updates 26 Apr, 12:36 PM Shree Ganesh Remedies commissions 2.5 MW Solar Power Project 25 Mar, 2:59 PM Shree Ganesh Remedies informs about outcome of board meeting 5 Feb, 5:23 PM Shree Ganesh Remedies informs about statement of utilization of proceeds of rights issue 5 Feb, 5:04 PM Shree Ganesh Remedies informs about outcome of board meeting 5 Feb, 4:55 PM Shree Ganesh Remed. - Quaterly Results 5 Feb, 2:58 PM Shree Ganesh Remed. - Quaterly Results 5 Feb, 2:58 PM Shree Ganesh Remed. - Quaterly Results 5 Feb, 2:58 PM Shree Ganesh Remedies executes supply agreement with Japanese firm 31 Jan, 10:16 AM Shree Ganesh Remedies informs about press release 31 Oct, 3:10 PM Shree Ganesh Remed. - Quaterly Results 29 Oct, 6:41 PM Shree Ganesh Remed. - Quaterly Results 29 Oct, 6:41 PM Shree Ganesh Remedies informs about analyst meet 26 Sep, 5:17 PM Shree Ganesh Remed. - Quaterly Results 12 Aug, 7:05 PM Shree Ganesh Remed. - Quaterly Results 12 Aug, 7:05 PM Shree Ganesh Remedies informs about newspaper advertisement 3 Jun, 5:34 PM Shree Ganesh Remedies informs about outcome of board meeting 1 Jun, 3:35 PM Shree Ganesh Remed. - Quaterly Results 1 Jun, 2:10 PM Shree Ganesh Remed. - Quaterly Results 1 Jun, 2:10 PM Shree Ganesh Remed. - Quaterly Results 1 Jun, 2:10 PM Shree Ganesh Remed. - Quaterly Results 12 Feb, 10:48 PM Shree Ganesh Remed. - Quaterly Results 12 Feb, 10:48 PM Shree Ganesh Remedies informs about newspaper publication 13 Nov, 1:02 PM Shree Ganesh Remedies incorporates wholly owned subsidiary in United States 25 Aug, 9:59 AM Shree Ganesh Remed. - Quaterly Results 31 Jul, 6:20 PM Shree Ganesh Remed. - Quaterly Results 31 Jul, 6:20 PM Shree Ganesh Remed. - Quaterly Results 31 Jul, 6:20 PM Shree Ganesh Remedies gets FDA license to manufacture products at Ankleshwar facility 13 Jul, 1:03 PM Shree Ganesh Remedies informs about analyst meet 20 Jun, 5:06 PM Shree Ganesh Remed. - Quaterly Results 30 May, 10:45 PM Shree Ganesh Remed. - Quaterly Results 30 May, 10:45 PM Shree Ganesh Remedies informs about update 27 Jan, 4:52 PM Shree Ganesh Remed. - Quaterly Results 16 Jan, 5:05 PM Shree Ganesh Remed. - Quaterly Results 16 Jan, 5:05 PM Shree Ganesh Remed. - Quaterly Results 16 Jan, 5:05 PM Shree Ganesh Remedies informs about clarification with regards to financial results 25 Oct, 12:54 PM Shree Ganesh Remedies informs about newspaper advertisement 25 Oct, 12:47 PM Shree Ganesh Remedies informs about outcome of board meeting 25 Oct, 10:56 AM

Shree Ganesh Remed. Stock Price Analysis and Quick Research Report. Is Shree Ganesh Remed. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Shree Ganesh Remed.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shree Ganesh Remed. has a PE ratio of 55.3376435587614 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shree Ganesh Remed. has ROA of 8.61% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shree Ganesh Remed. has a Current ratio of 3.3945.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shree Ganesh Remed. has a ROE of 11.5333%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Shree Ganesh Remed. has a Debt to Equity ratio of 0.1882 which means that the company has low proportion of debt in its capital.

  • Sales growth: Shree Ganesh Remed. has reported revenue growth of 0.6347% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Shree Ganesh Remed. for the current financial year is 32.0440532987817%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shree Ganesh Remed. is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Shree Ganesh Remed. is Rs 12.0334. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Shree Ganesh Remed. in Ticker for free. Also, one can get the intrinsic value of Shree Ganesh Remed. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Shree Ganesh Remed. FAQs

Q1. What is Shree Ganesh Remed. share price today?
Ans: The current share price of Shree Ganesh Remed. is Rs 665.9.

Q2. What is the market capitalisation of Shree Ganesh Remed.?
Ans: Shree Ganesh Remed. has a market capitalisation of Rs 854.8571158 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Shree Ganesh Remed.?
Ans: The PE ratio of Shree Ganesh Remed. is 55.3376435587614 and the P/B ratio of Shree Ganesh Remed. is 5.2082111253459, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Shree Ganesh Remed. share?
Ans: The 52-week high share price of Shree Ganesh Remed. is Rs 722, and the 52-week low share price of Shree Ganesh Remed. is Rs 477.05.

Q5. Does Shree Ganesh Remed. pay dividends?
Ans: Currently, Shree Ganesh Remed. does not pay dividends. Dividend yield of Shree Ganesh Remed. is around 0%.

Q6. What are the face value and book value of Shree Ganesh Remed. shares?
Ans: The face value of Shree Ganesh Remed. shares is Rs 10, while the book value per share of Shree Ganesh Remed. is around Rs 127.8558. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Shree Ganesh Remed.?
Ans: Shree Ganesh Remed. has a total debt of Rs 30.6722 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Shree Ganesh Remed.?
Ans: The ROE of Shree Ganesh Remed. is 11.5333% and ROCE of Shree Ganesh Remed. is 14.6247%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Shree Ganesh Remed. a good buy for the long term?
Ans: The Shree Ganesh Remed. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Shree Ganesh Remed. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Shree Ganesh Remed. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Shree Ganesh Remed.’s financials?
Ans: You can review Shree Ganesh Remed.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Shree Ganesh Remed.
X